Skip to main content

Main menu

  • Home
  • Content
    • Current issue
    • Past issues
    • Early releases
    • Collections
    • Sections
    • Blog
    • Infographics & illustrations
    • Podcasts
    • COVID-19 Articles
  • Authors
    • Overview for authors
    • Submission guidelines
    • Submit a manuscript
    • Forms
    • Editorial process
    • Editorial policies
    • Peer review process
    • Publication fees
    • Reprint requests
    • Open access
  • CMA Members
    • Overview for members
    • Earn CPD Credits
    • Print copies of CMAJ
  • Subscribers
    • General information
    • View prices
  • Alerts
    • Email alerts
    • RSS
  • JAMC
    • À propos
    • Numéro en cours
    • Archives
    • Sections
    • Abonnement
    • Alertes
    • Trousse média 2022
  • CMAJ JOURNALS
    • CMAJ Open
    • CJS
    • JAMC
    • JPN

User menu

Search

  • Advanced search
CMAJ
  • CMAJ JOURNALS
    • CMAJ Open
    • CJS
    • JAMC
    • JPN
CMAJ

Advanced Search

  • Home
  • Content
    • Current issue
    • Past issues
    • Early releases
    • Collections
    • Sections
    • Blog
    • Infographics & illustrations
    • Podcasts
    • COVID-19 Articles
  • Authors
    • Overview for authors
    • Submission guidelines
    • Submit a manuscript
    • Forms
    • Editorial process
    • Editorial policies
    • Peer review process
    • Publication fees
    • Reprint requests
    • Open access
  • CMA Members
    • Overview for members
    • Earn CPD Credits
    • Print copies of CMAJ
  • Subscribers
    • General information
    • View prices
  • Alerts
    • Email alerts
    • RSS
  • JAMC
    • À propos
    • Numéro en cours
    • Archives
    • Sections
    • Abonnement
    • Alertes
    • Trousse média 2022
  • Visit CMAJ on Facebook
  • Follow CMAJ on Twitter
  • Follow CMAJ on Pinterest
  • Follow CMAJ on Youtube
  • Follow CMAJ on Instagram
News

Ottawa Heart Institute producing alternative to technetium-99 isotopes

Becky Rynor
CMAJ May 18, 2010 182 (8) E325-E326; DOI: https://doi.org/10.1503/cmaj.109-3224
Becky Rynor
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Tables
  • Responses
  • Metrics
  • PDF
Loading

It was “more serendipity than foresight,” but research commenced more than a decade ago by a team at the University of Ottawa Heart Institute in Ontario could pave the way to finding alternatives for nuclear-produced medical isotopes.

Dr. Terrance Ruddy, director of nuclear cardiology at the institute, says the team of chemists, medical physicists and researchers began looking into alternatives to technetium-99 —the isotope most commonly used to treat and diagnose cancer, heart disease and other illness — long before current shortages sent medical facilities scrambling to secure supplies of isotopes. “It was more serendipity than foresight. But you can call it foresight if you want.”

The institute is now at the point where it is producing an alternative isotope — rubidium-82 — in a generator “about the size of a beer fridge,” Ruddy says. The isotope can be used in Positron Emission Tomography (PET) scans, which use traceable isotopes to light up organs or areas of disease. It is considered more accurate and safer because it exposes patients to less radiation.

“We wanted to be state-of-the-art for cardiac imaging,” Ruddy says. “But the same methodology can also be used for cancer imaging.”

The institute was also successful in obtaining funding for a cyclotron which is used to produce fluorine-18, which is attached to FDG to create a glucose-based radio-pharmaceutical used for PET cancer imaging and for looking at heart muscle metabolism.

Patients around the world are experiencing testing delays due to a shortage of isotopes caused by ongoing repairs at the National Research Universal reactor in Chalk River, Ontario, and the High Flux Reactor in Petter, the Netherlands. The Society of Nuclear Medicine warned on Mar. 18 that hospitals around the world will this summer face “one of the most significant disruptions ever,” of molybdenum-99, the radioactive substance that is used to produce technetium-99m (www.snm.org/index.cfm?PageID=9584).

Figure
  • Download figure
  • Open in new tab
  • Download powerpoint

Positron emission tomography scanners can be used for diagnostic testing in the face of shortages of technetium-99 isotopes, but they’re not a national solution because there aren’t enough of them in Canada “to make a major dent,” says Dr. Rob Beanlands, chief of cardiac imaging at the Ottawa Heart Institute in Ontario. Image courtesy of © 2010 Jupiterimages Corp.

But Ottawa-area residents are getting crucial diagnostic imaging tests, Ruddy says. “There are no cancer patients not getting their bone scans. It’s the non-cancer indication bone scans that are being redirected. We’re triaging, and then recommending similar alternative tests with similar diagnostic accuracy.”

Guy Morency, a spokesman for the nuclear medicine departments at five Ottawa-area hospitals, says “all urgent patients are being done. It is just those that we would deem to be more of an elective style or follow-up that needs to be confirmed. And those are getting done within one to five days.”

“We can replace a lot of the technetium use with thallium (another tracer) or with our PET studies,” Ruddy says. “By us giving up the technetium — and we’re a large user — that meant there was more available for the rest of the community,” including other area hospitals and private clinics.

Still, the situation is not ideal, says Dr. Rob Beanlands, chief of cardiac imaging at the Ottawa Heart Institute. “Nobody is being turned away and nobody is being cancelled and nobody is waiting any significantly different length of time than before this happened. But it’s because we had a game plan with the thallium. We have a large cardiac volume that meant our technitium could be shifted over to the cancer folks and because of some of the research we’ve doing with the (single photon emission computed tomography) cameras and the PET tracers.”

It’s also not a national solution to isotope shortages, Beanlands adds. PET cameras are costly — about $3 million each — and there aren’t enough of them across Canada, “to make a major dent.”

Canadian Society of Nuclear Medicine President Dr. Jean-Luc Urbain concurs. “Ottawa is in a totally different predicament and you cannot equate an academic centre to a community situation.”

“The problem is that there are not enough PET scanners, rubidium is much more expensive and it’s more labour intensive,” Urbain adds. “It’s very difficult to do these types of studies outside of the academic environment.”

“Academically, yes, it can be done. Is it viable, socio-economically, for nonacademic centres in Canada and the rest of the world? Not yet. It’s not economically feasible outside the academic setting and won’t be for a long time.”

Still, both Ruddy and Beanlands argue that it is “crucial” that research continue into the use of alternatives, including forms of diagnostic testing that do not involve the use of isotopes.

Footnotes

  • Published at www.cmaj.ca on Mar. 31

PreviousNext
Back to top

In this issue

Canadian Medical Association Journal: 182 (8)
CMAJ
Vol. 182, Issue 8
18 May 2010
  • Table of Contents
  • Index by author

Article tools

Respond to this article
Print
Download PDF
Article Alerts
To sign up for email alerts or to access your current email alerts, enter your email address below:
Email Article

Thank you for your interest in spreading the word on CMAJ.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Ottawa Heart Institute producing alternative to technetium-99 isotopes
(Your Name) has sent you a message from CMAJ
(Your Name) thought you would like to see the CMAJ web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Ottawa Heart Institute producing alternative to technetium-99 isotopes
Becky Rynor
CMAJ May 2010, 182 (8) E325-E326; DOI: 10.1503/cmaj.109-3224

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
‍ Request Permissions
Share
Ottawa Heart Institute producing alternative to technetium-99 isotopes
Becky Rynor
CMAJ May 2010, 182 (8) E325-E326; DOI: 10.1503/cmaj.109-3224
Digg logo Reddit logo Twitter logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like

Jump to section

  • Article
    • Footnotes
  • Figures & Tables
  • Responses
  • Metrics
  • PDF

Related Articles

  • No related articles found.
  • PubMed
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

  • Longer family medicine residency: Boon or bane to doctor supply?
  • The evolving picture of long COVID
  • When are shared decisions false choices?
Show more News

Similar Articles

 

View Latest Classified Ads

Content

  • Current issue
  • Past issues
  • Collections
  • Sections
  • Blog
  • Podcasts
  • Alerts
  • RSS
  • Early releases

Information for

  • Advertisers
  • Authors
  • Reviewers
  • CMA Members
  • Media
  • Reprint requests
  • Subscribers

About

  • General Information
  • Journal staff
  • Editorial Board
  • Advisory Panels
  • Governance Council
  • Journal Oversight
  • Careers
  • Contact
  • Copyright and Permissions
  • Accessibiity
  • CMA Civility Standards
CMAJ Group

Copyright 2022, CMA Impact Inc. or its licensors. All rights reserved. ISSN 1488-2329 (e) 0820-3946 (p)

All editorial matter in CMAJ represents the opinions of the authors and not necessarily those of the Canadian Medical Association or its subsidiaries.

To receive any of these resources in an accessible format, please contact us at CMAJ Group, 500-1410 Blair Towers Place, Ottawa ON, K1J 9B9; p: 1-888-855-2555; e: cmajgroup@cmaj.ca

Powered by HighWire